about
Peritoneal Dialysis in Western CountriesRegulation of synthesis and roles of hyaluronan in peritoneal dialysisEffect of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions on Residual Renal Function, Urine Volume, and Ultrafiltration: A Systematic Review and Meta-AnalysisThe Current State of Peritoneal DialysisRationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal functionImproving survival rate of Korean patients initiating dialysisThe solution to better preservation of the peritoneal membrane still lies hidden in the solution.Recent advances in the management of peritoneal dialysis patients.Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic PatientsISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors.Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis.Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids.Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial.Trials (and tribulations) of biocompatible peritoneal dialysis fluidsSkin Autofluorescence and Mortality in Patients on Peritoneal Dialysis.Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patientsDifficult peritonitis cases in children undergoing chronic peritoneal dialysis: relapsing, repeat, recurrent and zoonotic episodes.Strategies for preserving residual renal function in peritoneal dialysis patientsPeritoneal dialysis practice in Australia and New Zealand: A call to sustain the action.The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients.Is there such a thing as biocompatible peritoneal dialysis fluid?STANDARDIZED OUTCOMES IN NEPHROLOGY-PERITONEAL DIALYSIS (SONG-PD): STUDY PROTOCOL FOR ESTABLISHING A CORE OUTCOME SET IN PD.33 Years of Peritoneal Dialysis-Associated Peritonitis: A Single-Center Study in Japan.Functional and Transcriptomic Characterization of Peritoneal Immune-Modulation by Addition of Alanyl-Glutamine to Dialysis Fluid.Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.The Complement System in Dialysis: A Forgotten Story?Complement Activation in Peritoneal Dialysis-Induced Arteriolopathy.The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
P2860
Q26740468-9F239F71-42C9-40A8-9C11-7EBB64312C61Q26778414-94B44169-B19D-4E61-940C-5AA84F828550Q26852444-4F8B36E5-FC98-412B-BACA-9441B65143B2Q30243902-E538E085-E66A-44FA-9DD7-91074EE40B06Q33693392-E51F6FE6-B5A2-4015-BF70-4014469EA179Q35421557-ABA6B087-874E-46AC-9AA5-A48195F6DC7AQ35524650-7D5FF524-C083-4DDE-A4BE-936823F7F39EQ35659309-2B9F0FD2-8A81-4446-9F9E-37C8B0A198D8Q35902232-9047AC35-F1A2-41A2-B6D1-CCCB782E1A65Q35904398-016FB6D7-3F1B-485A-AACA-BA5EF7C462B9Q36022479-CDE70D65-E61E-4D31-8C71-F0DE1BDA643EQ36059841-84D2BF23-CEC8-4C46-B110-EE269705D68EQ36170797-2035E7C5-564C-4D24-B446-653D3EDE10DBQ36475670-C329DC06-DE02-4B89-9C8F-54A8CE804A0FQ37016642-ACAABEDF-321F-45FC-81FE-0CD97DF534DDQ37715008-BF772385-6D43-4B38-A6F9-9D4E850193A8Q38251157-CB4FEC85-96CA-4B55-8BF0-85FD9C2DF487Q38393215-05CB62C7-F4BC-48F1-B5CA-8D4A77872045Q38710566-3302B698-21D0-4409-B1CE-CAABED0272E4Q38798159-401247C7-9337-4889-A271-C00698CF3919Q38976940-9D246948-8DD0-4FBB-ABC9-D4AF55FEBD9BQ39210349-1F53E4EB-8313-41DF-8F48-0BB9E9B5EE88Q40312576-40388B04-5B68-45B1-B81F-3C7AD3D93A63Q41108686-41CCB1A2-1EF0-42A4-A8CB-AFC8DD8204ADQ47128504-EAEA5817-A1ED-4ED2-8353-6274A7E66A59Q49401359-C6CFEECE-FC46-42DA-9F7D-A63E8C50B1FAQ50091275-EBE34F4E-DCB6-4EFE-A4E6-65F5D59B3689Q51711089-73A1F534-3001-4A0A-8C6B-20C2D086311A
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biocompatible dialysis fluids for peritoneal dialysis
@ast
Biocompatible dialysis fluids for peritoneal dialysis
@en
Biocompatible dialysis fluids for peritoneal dialysis
@en-gb
Biocompatible dialysis fluids for peritoneal dialysis
@nl
type
label
Biocompatible dialysis fluids for peritoneal dialysis
@ast
Biocompatible dialysis fluids for peritoneal dialysis
@en
Biocompatible dialysis fluids for peritoneal dialysis
@en-gb
Biocompatible dialysis fluids for peritoneal dialysis
@nl
prefLabel
Biocompatible dialysis fluids for peritoneal dialysis
@ast
Biocompatible dialysis fluids for peritoneal dialysis
@en
Biocompatible dialysis fluids for peritoneal dialysis
@en-gb
Biocompatible dialysis fluids for peritoneal dialysis
@nl
P2093
P2860
P50
P3181
P1476
Biocompatible dialysis fluids for peritoneal dialysis
@en
P2093
Giovanni F M Strippoli
Kathryn J Wiggins
Yeoungjee Cho
P2860
P304
P3181
P356
10.1002/14651858.CD007554.PUB2
P577
2014-03-27T00:00:00Z